BPMC
Janus Henderson Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5M | Buy |
268,928
+240,179
| +835% | +$30.8M | 0.02% | 462 |
|
|
2025
Q1 | $2.55M | Hold |
28,749
| – | – | ﹤0.01% | 1160 |
|
|
2024
Q4 | $2.51M | Hold |
28,749
| – | – | ﹤0.01% | 1202 |
|
|
2024
Q3 | $2.66M | Hold |
28,749
| – | – | ﹤0.01% | 1167 |
|
|
2024
Q2 | $3.1M | Sell |
28,749
-308
| -1% | -$33.2K | ﹤0.01% | 1050 |
|
|
2024
Q1 | $2.75M | Sell |
29,057
-1
| -0% | -$95 | ﹤0.01% | 1135 |
|
|
2023
Q4 | $2.68M | Sell |
29,058
-44
| -0.2% | -$4.06K | ﹤0.01% | 1092 |
|
|
2023
Q3 | $1.46M | Buy |
29,102
+4
| +0% | +$201 | ﹤0.01% | 1349 |
|
|
2023
Q2 | $1.84M | Buy |
29,098
+5,667
| +24% | +$358K | ﹤0.01% | 1291 |
|
|
2023
Q1 | $1.05M | Buy |
23,431
+12,221
| +109% | +$549K | ﹤0.01% | 1600 |
|
|
2022
Q4 | $491K | Sell |
11,210
-11,210
| -50% | -$491K | ﹤0.01% | 1726 |
|
|
2022
Q3 | $1.48M | Buy |
22,420
+11,234
| +100% | +$741K | ﹤0.01% | 1446 |
|
|
2022
Q2 | $565K | Sell |
11,186
-17
| -0.2% | -$859 | ﹤0.01% | 1696 |
|
|
2022
Q1 | $716K | Buy |
11,203
+3
| +0% | +$192 | ﹤0.01% | 1687 |
|
|
2021
Q4 | $1.2M | Buy |
11,200
+5,637
| +101% | +$604K | ﹤0.01% | 1436 |
|
|
2021
Q3 | $572K | Buy |
+5,563
| New | +$572K | ﹤0.01% | 1551 |
|
|
2018
Q1 | – | Sell |
-15,000
| Closed | -$1.13M | – | 1361 |
|
|
2017
Q4 | $1.13M | Buy |
+15,000
| New | +$1.13M | ﹤0.01% | 1168 |
|
|
2017
Q2 | – | Sell |
-30,000
| Closed | -$1.2M | – | 1309 |
|
|
2017
Q1 | $1.2M | Buy |
+30,000
| New | +$1.2M | 0.01% | 637 |
|